AvertD

Those with higher genetic risk for opioid use disorder can be unsuspecting victims of addiction. Genetics is an important piece of the puzzle—and AvertD, the first U.S. Food and Drug Administration-approved genetic test for assessing elevated risk of OUD, is helping providers see the whole picture.

Learn more: https://avertdtest.com/

Today, we celebrate the vital role pharmacists play in safeguarding patient health. Pharmacists can be a first line of defense in ensuring patients understand the risks associated with opioid use and the importance of safer pain management options.

Their dedication to educating patients and supporting informed healthcare decisions is invaluable in the fight against the opioid crisis.

Thank you to pharmacists everywhere for your commitment to improving lives and advancing health!

Approximately 1 in 16 patients prescribed opioids will use them long-term, significantly increasing their risk for opioid use disorder (OUD). Understanding individual risk is a critical step in preventing opioid misuse and promoting safer pain management.

With patient health outcomes at the forefront, AvertD® empowers healthcare providers to personalize care, support informed decision-making, and help protect patients from potential harm.

Learn more about how AvertD® is shaping the future of personalized care: https://avertdtest.com/

Recent CDC data indicates a significant decline in U.S. drug overdose deaths, with a nearly 17% drop reported in the 12 months ending in June 2024, totaling 93,087 fatalities. This marks the first time since 2020 that annual overdose deaths have fallen below 100,000. While this trend is encouraging, the opioid crisis remains a critical public health challenge.

Continued efforts in prevention, treatment, and education are essential to sustain and accelerate this progress. AvertD® is proud to be empowering patients and providers with actionable insights that could prevent opioid use disorder.

NPR shares more details about the recent developments: https://www.npr.org/2024/11/14/nx-s1-5191743/overdose-deaths-drop-fentanyl-opioid-crisis

'Historic' drop in U.S. overdose deaths accelerates as fentanyl crisis eases A new CDC report shows at least 16,000 lives were saved over a 12-month period. Experts say the U.S. is experiencing the biggest drop in fatal overdoses seen since the opioid crisis began in the 90s.